Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Queensland Centre for Gynaecological Cancer
Qilu Pharmaceutical Co., Ltd.
Fujian Medical University
Fudan University
Johannes Gutenberg University Mainz
Shanghai Chest Hospital
Samsung Medical Center
University of Alexandria